MR imaging texture analysis of the corpus callosum and thalamus in amnestic mild cognitive impairment and mild Alzheimer disease.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 20966061)

Published in AJNR Am J Neuroradiol on October 21, 2010

Authors

M S de Oliveira1, M L F Balthazar, A D'Abreu, C L Yasuda, B P Damasceno, F Cendes, G Castellano

Author Affiliations

1: Department of Cosmic Rays and Chronology, Institute of Physics Gleb Wataghin, University of Campinas, São Paulo, Brazil. marciaso@ifi.unicamp.br

Articles by these authors

Texture analysis of medical images. Clin Radiol (2004) 2.73

Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann Neurol (1999) 2.67

Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut (2005) 2.35

Surgical outcome in patients with epilepsy and dual pathology. Brain (1999) 2.19

[Multiple anisakiasis]. Rev Esp Enferm Dig (2008) 2.09

Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain (1995) 2.06

Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet (1994) 1.95

Neuroimaging findings in scleroderma en coup de sabre. Neurology (2004) 1.87

Medial temporal lobe atrophy in patients with refractory temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (2003) 1.79

pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. J Am Chem Soc (2001) 1.74

Antibody responses in acute and chronic rubella. Proc Soc Exp Biol Med (1966) 1.66

Volumetric magnetic resonance imaging. Clinical applications and contributions to the understanding of temporal lobe epilepsy. Arch Neurol (1997) 1.66

IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am J Transplant (2011) 1.62

Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal. Neurology (2006) 1.61

Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer's disease. Eur J Neurol (2009) 1.51

Idiopathic thrombocytopenic purpura and pancytopenia in a patient with Crohn's disease: a new association. Am J Gastroenterol (1996) 1.41

Learning and retention of words and designs following excision from medial or lateral temporal-lobe structures. Neuropsychologia (1997) 1.31

3T MRI quantification of hippocampal volume and signal in mesial temporal lobe epilepsy improves detection of hippocampal sclerosis. AJNR Am J Neuroradiol (2013) 1.22

Asymmetrical extra-hippocampal grey matter loss related to hippocampal atrophy in patients with medial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (2006) 1.22

Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology (2009) 1.20

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry (2007) 1.15

Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology (2001) 1.13

Mesial atrophy and outcome after amygdalohippocampectomy or temporal lobe removal. Ann Neurol (1996) 1.13

Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol (2000) 1.13

Evaluation of various plastic microtiter plates with measles, toxoplasma, and gamma globulin antigens in enzyme-linked immunosorbent assays. J Clin Microbiol (1984) 1.12

Hippocampal atrophy and T2-weighted signal changes in familial mesial temporal lobe epilepsy. Neurology (2003) 1.09

[Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies]. Med Clin (Barc) (1992) 1.07

Clinical patterns of patients with temporal lobe epilepsy and pure amygdalar atrophy. Epilepsia (1999) 1.05

[Eosinophilic cholecystitis: an infrequent cause of cholecystectomy]. Gastroenterol Hepatol (1997) 1.03

Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C. J Hepatol (2000) 1.01

Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis (2006) 1.00

Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine. Mol Immunol (2008) 0.98

Differences in memory performance and other clinical characteristics in patients with mesial temporal lobe epilepsy with and without hippocampal atrophy. Epilepsy Behav (2004) 0.97

Painful supernumerary phantom arm following motor cortex stimulation for central poststroke pain. Case report. J Neurosurg (1999) 0.96

Ischemia-reperfusion injury-induced abnormal dendritic cell traffic in the transplanted kidney with delayed graft function. Kidney Int (2007) 0.96

Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy. Epilepsia (2001) 0.96

MRI reveals structural abnormalities in patients with idiopathic generalized epilepsy. Neurology (2006) 0.96

Focal intermittent delta activity in patients with mesiotemporal atrophy: a reliable marker of the epileptogenic focus. Epilepsia (1995) 0.96

Contribution of medial versus lateral temporal-lobe structures to human odour identification. Brain (1997) 0.94

Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost (2000) 0.93

Antiepileptic drug response in temporal lobe epilepsy: a clinical and MRI morphometry study. Neurology (2010) 0.92

Confirmation of the SCA-2 locus as an alternative locus for dominantly inherited spinocerebellar ataxias and refinement of the candidate region. Am J Hum Genet (1994) 0.92

Spatial extent of neuronal metabolic dysfunction measured by proton MR spectroscopic imaging in patients with localization-related epilepsy. Epilepsia (2000) 0.92

Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Ann Neurol (2000) 0.92

Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2000) 0.92

Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol (1987) 0.91

Developmental language disorder associated with polymicrogyria. Neurology (2002) 0.91

Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. Prog Brain Res (2002) 0.90

Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years. Transplant Proc (2010) 0.90

Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology (1997) 0.90

Nocturnal temporal lobe epilepsy. Neurology (1998) 0.89

Patterns of hippocampal abnormalities in malformations of cortical development. J Neurol Neurosurg Psychiatry (2006) 0.89

Cerebellar ataxia in systemic lupus erythematosus. Lupus (2008) 0.89

Use of radionuclide angiography and an electrocardiographic stress test to diagnose multivessel disease after a first episode of uncomplicated myocardial infarction. Br Heart J (1986) 0.88

Esophagitis dissecans superficialis (esophageal cast) complicating esophageal sclerotherapy. Am J Gastroenterol (1998) 0.87

The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg (2010) 0.87

Late onset temporal lobe epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis: case report. Arq Neuropsiquiatr (2001) 0.87

Relations between EEG seizure morphology, interhemispheric spread, and mesial temporal atrophy in bitemporal epilepsy. Epilepsia (1997) 0.87

Diagnosis of subtle focal dysplastic lesions: curvilinear reformatting from three-dimensional magnetic resonance imaging. Ann Neurol (1999) 0.87

Late-onset drop attacks in temporal lobe epilepsy: a reevaluation of the concept of temporal lobe syncope. Neurology (1994) 0.86

Curvilinear reconstruction of 3D magnetic resonance imaging in patients with partial epilepsy: a pilot study. Magn Reson Imaging (1995) 0.86

Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients. Am J Transplant (2010) 0.85

Dentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxia. Eur J Neurol (2014) 0.84

Correlation between fibroscan, liver biopsy, and clinical liver function in patients with hepatitis C virus infection after renal transplantation. Transplant Proc (2009) 0.84

Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat. Braz J Med Biol Res (2006) 0.84

Proton magnetic resonance spectroscopic imaging in patients with extratemporal epilepsy. Epilepsia (1998) 0.84

Focal status epilepticus as the first manifestation of paracoccidioidomycosis. Eur J Neurol (2005) 0.84

Influence of remote substituents on the equatorial/axial selectivity in the monooxygenation of methylene C--H bonds of substituted cyclohexanes. J Am Chem Soc (2001) 0.83

Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients. J Am Soc Nephrol (1998) 0.83

Nodular regenerative hyperplasia of the liver associated with the toxic oil syndrome: report of five cases. Hepatology (1986) 0.83

Medial temporal lobe neuronal damage in temporal and extratemporal lesional epilepsy. Neurology (2000) 0.83

Specificity of volumetric magnetic resonance imaging in detecting hippocampal sclerosis. Arch Neurol (1997) 0.83

The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients. Q J Nucl Med Mol Imaging (2012) 0.83

Effectiveness of histopathological diagnoses in dysfunction of hepatic transplantation. Review of 146 histopathological studies from 53 transplants. Arch Pathol Lab Med (1991) 0.83

Safe endoscopic resection of gangliocytic paraganglioma of the major duodenal papilla. Rev Esp Enferm Dig (2004) 0.82

Neuroimaging of the cortical dysplasias. Neurology (2004) 0.82

Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus. Rheumatology (Oxford) (2006) 0.82

Sleep symptoms and their clinical correlates in Machado-Joseph disease. Acta Neurol Scand (2008) 0.82

Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study. Neurology (1998) 0.82

Excessive daytime sleepiness and on-road driving performance in patients with Parkinson's disease. J Neurol Sci (2006) 0.82

Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus. Lupus (2007) 0.82

Cerebral cortex involvement in Machado-Joseph disease. Eur J Neurol (2014) 0.81

Predicting surgical outcome in temporal lobe epilepsy patients using MRI and MRSI. Neurology (2002) 0.81

The role of cortex in central pain syndromes: preliminary results of a long-term technetium-99 hexamethylpropyleneamineoxime single photon emission computed tomography study. Neurosurgery (1993) 0.81

Function and organization in dysgenic cortex. Case report. J Neurosurg (1997) 0.81

The immunomodulator glatiramer acetate influences spinal motoneuron plasticity during the course of multiple sclerosis in an animal model. Braz J Med Biol Res (2009) 0.80

Intracranial aneurysms and sickle cell anemia: multiplicity and propensity for the vertebrobasilar territory. Neurosurgery (1998) 0.80

Lateralization of temporal lobe epilepsy (TLE) and discrimination of TLE from extra-TLE using pattern analysis of magnetic resonance spectroscopic and volumetric data. Epilepsia (2000) 0.79

Dynamic renal scanning using 99mTc-MAG-3 in man. Eur J Nucl Med (1989) 0.79

Relationship between environmental factors and gray matter atrophy in refractory MTLE. Neurology (2010) 0.79

Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int (1995) 0.79